N-(Azetidin-3-yl)acetamide hydrochloride
97%
- Product Code: 124533
CAS:
102065-92-9
| Molecular Weight: | 150.61 g./mol | Molecular Formula: | C₅H₁₁ClN₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD08059477 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of molecules targeting various biological pathways, such as enzyme inhibition or receptor modulation. Its structural features, including the azetidine ring, make it valuable for designing compounds with enhanced bioavailability and metabolic stability. Researchers also explore its potential in developing treatments for neurological disorders, inflammation, and cancer due to its ability to interact with specific cellular targets. Additionally, it is used in medicinal chemistry to optimize pharmacokinetic properties of lead compounds during drug discovery processes.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿5,967.00 |
+
-
|
| 1.000 | 10-20 days | ฿11,934.00 |
+
-
|
| 5.000 | 10-20 days | ฿31,590.00 |
+
-
|
N-(Azetidin-3-yl)acetamide hydrochloride
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of molecules targeting various biological pathways, such as enzyme inhibition or receptor modulation. Its structural features, including the azetidine ring, make it valuable for designing compounds with enhanced bioavailability and metabolic stability. Researchers also explore its potential in developing treatments for neurological disorders, inflammation, and cancer due to its ability to interact with specific cellular targets. Additionally, it is used in medicinal chemistry to optimize pharmacokinetic properties of lead compounds during drug discovery processes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :